DYN - Dynegy Inc. Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 BTCUSD (%) SPY (0.33%) AQMS (5.77%) BNBUSD (%) ETHUSD (%) LTCUSD (%) NIO (1.21%) MANAUSD (%) MA (-0.09%) LINKUSD (%) LB (0.09%) GGB (1.05%) GECC (0.91%) FB (-0.53%) ESNT (0.7%) DXC (-0.97%) DOGEUSD (%) DGLY (-1.78%) DDD (1.43%) CZR (0.52%) CPRI (0.43%) CLDR (-2.88%) BHAT (-2.59%) BABA (-0.17%) ALGN (0.02%)

Next Earnings Date : 5/1/2021

DYN - Dynegy Inc.

$17.45 -0.08[-0.46%]

15 mins delayed data

People also watch :

+Watchlist

2 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$17.53	Open	$17.70
Volume	195.8K	Market Cap	1.85B
Yield		Last Dividend

Day

52 Week

Dyne Therapeutics (NASDAQ:DYN) Posts Ear...	03/06/21
Dyne Therapeutics (NASDAQ:DYN) announced its quarterly earnings results on Wednesday. The company reported ($0.64) earnings per share for the quarter,...

The Daily Biotech Pulse: Fulgent's Big Q...	03/05/21
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 4) Atr...

Dyne Therapeutics Appoints Wildon Farwel...	03/04/21
Seasoned Clinical Leader Brings Deep Experience in Drug Development, Including Approval of an Oligonucleotide Therapy in Neuromuscular Disease WALTHAM...

Dyne Therapeutics Earnings and Growth An...	02/17/21
Dyne Therapeutics announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by???

Mid-Day Market Update: Nasdaq Rises Over...	01/21/21
Midway through trading opening Thursday, the Dow traded down 0.12% to 31,150.37 while the NASDAQ rose 0.37% to 13,507.06. The S&P also fell, dropping ...

EFFECT - Dyne Therapeutics, Inc. (000181...	01/21/21
Accepted 2021-01-21 00:16:06 Documents Stock Market Shirts \| Stock Trading Mugs \| Stock Trader Decor \| Investing Books 1 Effectiveness Date 2021-01-20...

Dyne Therapeutics Announces Pricing of $...	01/20/21
WALTHAM, Mass., Jan. 20, 2021 (GLOBE NEWSWIRE) ??? Dyne Therapeutics, Inc. (NASDAQ:DYN), a muscle disease company focused on advancing innovative life...

The Daily Biotech Pulse: Bausch Health I...	01/13/21
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12) Abb...

The Daily Biotech Pulse: GSK, Vir To Sta...	01/12/21
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 11) 10X...

Dyne Therapeutics Myotonic Dystrophy Typ...	01/10/21
- In Vivo Model Developed by Dyne Sets New Standard for Evaluating Pharmacodynamics in DM1 - - Preclinical Data Further Validate FORCE??? Platform; IN...

Dyne Therapeutics Reports Third Quarter ...	11/05/20
- Successful Financings, including $268 Million Initial Public Offering and $116 Million Series B Expected to Fund Through Proof of Concept Data in Co...

The Daily Biotech Pulse: Amarin Vascepa ...	10/16/20
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 15) Ami...

The Daily Biotech Pulse: Bristol-Myers S...	10/07/20
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) 10X ...

The Daily Biotech Pulse: Eton Snags Seco...	09/30/20
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Ac...

Citadel Advisors takes 6.5% passive stak...	09/28/20
Citadel Advisors purchases ~2.9M shares of Dyne Therapeutics (NASDAQ:DYN). Shares represent approximately 6.5% of total shares. Shares +2.8% AH Press ...

ANALYST RATINGS

0 analyst ratings (Last 3 months)

0.00 %

Strong Buy + Buy

Price Target (PT)

EARNINGS

Date	2021-03-04 (BMO)	Est. (EPS/Rev.)	($0.37)/ 0
Actual (EPS/Rev.)	$-0.64/	EPS (TTM)	0

TRADERS TRACKING $DYN

Service Name	Trader	% Success
Alpha Swing Trades	Jonathan	68.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.